0001209191-21-014976.txt : 20210226 0001209191-21-014976.hdr.sgml : 20210226 20210226183128 ACCESSION NUMBER: 0001209191-21-014976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210226 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu David Y CENTRAL INDEX KEY: 0001675881 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 21692490 MAIL ADDRESS: STREET 1: C/O PROTAGONIST THERAPEUTICS, INC. STREET 2: 521 COTTONWOOD DRIVE, SUITE 100 CITY: MILPITAS STATE: CA ZIP: 95035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-26 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001675881 Liu David Y C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 0 1 0 0 Chief Scientific Officer Common Stock 2021-02-26 4 A 0 10000 0.00 A 62427 D Stock Option (right to buy) 23.57 2021-02-26 4 A 0 65000 0.00 A 2031-02-25 Common Stock 65000 65000 D Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024. Includes an aggregate of 2,625 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2019 and March 9, 2020. The stock option vests in 48 equal monthly installments following the date of grant. /s/ Donald A. Kalkofen, Attorney-in-Fact for David Y. Liu 2021-02-26